150 related articles for article (PubMed ID: 10464074)
1. Chronic beryllium disease and cancer risk estimates with uncertainty for beryllium released to the air from the Rocky Flats Plant.
McGavran PD; Rood AS; Till JE
Environ Health Perspect; 1999 Sep; 107(9):731-44. PubMed ID: 10464074
[TBL] [Abstract][Full Text] [Related]
2. Stochastic estimates of exposure and cancer risk from carbon tetrachloride released to the air from the rocky flats plant.
Rood AS; McGavran PD; Aanenson JW; Till JE
Risk Anal; 2001 Aug; 21(4):675-95. PubMed ID: 11726020
[TBL] [Abstract][Full Text] [Related]
3. Retrospective beryllium exposure assessment at the Rocky Flats Environmental Technology Site.
Barnard AE; Torma-Krajewski J; Viet SM
Am Ind Hyg Assoc J; 1996 Sep; 57(9):804-8. PubMed ID: 8865588
[TBL] [Abstract][Full Text] [Related]
4. Chronic beryllium disease and beryllium sensitization at Rocky Flats: a case-control study.
Viet SM; Torma-Krajewski J; Rogers J
AIHAJ; 2000; 61(2):244-54. PubMed ID: 10782196
[TBL] [Abstract][Full Text] [Related]
5. A model for a comprehensive assessment of exposure and lifetime cancer incidence risk from plutonium released from the Rocky Flats Plant, 1953-1989.
Rood AS; Grogan HA; Till JE
Health Phys; 2002 Feb; 82(2):182-212. PubMed ID: 11797893
[TBL] [Abstract][Full Text] [Related]
6. Risks to the public from historical releases of radionuclides and chemicals at the Rocky Flats Environmental Technology Site.
Till JE; Rood AS; Voillequé PG; McGavran PD; Meyer KR; Grogan HA; Sinclair WK; Aanenson JW; Meyer HR; Mohler HJ; Rope SK; Case MJ
J Expo Anal Environ Epidemiol; 2002 Sep; 12(5):355-72. PubMed ID: 12198584
[TBL] [Abstract][Full Text] [Related]
7. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
[TBL] [Abstract][Full Text] [Related]
8. A comparison and critique of historical and current exposure assessment methods for beryllium: implications for evaluating risk of chronic beryllium disease.
Kolanz ME; Madl AK; Kelsh MA; Kent MS; Kalmes RM; Paustenbach DJ
Appl Occup Environ Hyg; 2001 May; 16(5):593-614. PubMed ID: 11370938
[TBL] [Abstract][Full Text] [Related]
9. Development of an eight-hour occupational exposure limit for beryllium.
Wambach PF; Tuggle RM
Appl Occup Environ Hyg; 2000 Jul; 15(7):581-7. PubMed ID: 10893794
[TBL] [Abstract][Full Text] [Related]
10. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
Kent MS; Robins TG; Madl AK
Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
[TBL] [Abstract][Full Text] [Related]
11. Application of beryllium antibodies in risk assessment and health surveillance: two case studies.
Clarke SM; Thurlow SM; Hilmas DE
Toxicol Ind Health; 1995; 11(4):399-411. PubMed ID: 8748421
[TBL] [Abstract][Full Text] [Related]
12. Summary of historical beryllium uses and airborne concentration levels at Los Alamos National Laboratory.
Stefaniak AB; Weaver VM; Cadorette M; Puckett LG; Schwartz BS; Wiggs LD; Jankowski MD; Breysse PN
Appl Occup Environ Hyg; 2003 Sep; 18(9):708-15. PubMed ID: 12909539
[TBL] [Abstract][Full Text] [Related]
13. Beryllium Exposure Control Program at the Cardiff Atomic Weapons Establishment in the United Kingdom.
Johnson JS; Foote K; McClean M; Cogbill G
Appl Occup Environ Hyg; 2001 May; 16(5):619-30. PubMed ID: 11370940
[TBL] [Abstract][Full Text] [Related]
14. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 1: historical exposure reconstruction.
Virji MA; Park JY; Stefaniak AB; Stanton ML; Day GA; Kent MS; Kreiss K; Schuler CR
Scand J Work Environ Health; 2012 May; 38(3):247-58. PubMed ID: 21850365
[TBL] [Abstract][Full Text] [Related]
15. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
[TBL] [Abstract][Full Text] [Related]
16. Government laboratory worker with lung cancer: comparing risks from beryllium, asbestos, and tobacco smoke.
Steinmaus C; Balmes JR
Environ Health Perspect; 2000 Oct; 108(10):1003-6. PubMed ID: 11049824
[TBL] [Abstract][Full Text] [Related]
17. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.
Deubner D; Kelsh M; Shum M; Maier L; Kent M; Lau E
Appl Occup Environ Hyg; 2001 May; 16(5):579-92. PubMed ID: 11370937
[TBL] [Abstract][Full Text] [Related]
18. Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk.
McCawley MA; Kent MS; Berakis MT
Appl Occup Environ Hyg; 2001 May; 16(5):631-8. PubMed ID: 11370941
[TBL] [Abstract][Full Text] [Related]
19. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
[TBL] [Abstract][Full Text] [Related]
20. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant.
Henneberger PK; Cumro D; Deubner DD; Kent MS; McCawley M; Kreiss K
Int Arch Occup Environ Health; 2001 Apr; 74(3):167-76. PubMed ID: 11355290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
